Hana Pharm Co Ltd
KRX:293480
Hana Pharm Co Ltd
Pre-Tax Income
Hana Pharm Co Ltd
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hana Pharm Co Ltd
KRX:293480
|
Pre-Tax Income
₩25.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Pre-Tax Income
₩61.4B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-6%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Pre-Tax Income
₩72.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Pre-Tax Income
₩171.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
16%
|
CAGR 10-Years
17%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Pre-Tax Income
₩11B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-6%
|
|
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Pre-Tax Income
₩22.4B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
39%
|
CAGR 10-Years
18%
|
|
Hana Pharm Co Ltd
Glance View
Hana Pharm Co., Ltd. engages in the research, development, and manufacture of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 657 full-time employees. The company went IPO on 2018-10-02. The company’s main products include cardiovascular drugs involves hypertension and hyperlipidemia medicines, as well as blood circulation improvement drugs; analgesics for severe pain and anesthetics for surgery and sedation; as well as gastrointestinal drugs such as peptic ulcer treatment and antispasmodics. The firm also provides antibiotics, dermatology analgesics, antipyretics and anti-inflammatory drugs.
See Also
What is Hana Pharm Co Ltd's Pre-Tax Income?
Pre-Tax Income
25.4B
KRW
Based on the financial report for Dec 31, 2024, Hana Pharm Co Ltd's Pre-Tax Income amounts to 25.4B KRW.
What is Hana Pharm Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-6%
Over the last year, the Pre-Tax Income growth was -9%. The average annual Pre-Tax Income growth rates for Hana Pharm Co Ltd have been -11% over the past three years , -6% over the past five years .
You don't have any saved screeners yet